Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8177 - 8184 of 12008 results
FDA Releases Draft Guidance for 3D Printed Medical Devices
May 17, 2016| Blog| Viewpoint
Renewable Energy Tax Credits: Recent IRS Notice Favorable to the Renewable Energy Industry
May 17, 2016| Alert| Viewpoint
UPDATE: Subject Matter Eligibility under 35 U.S.C. § 101 – Abstract Ideas
May 17, 2016| Alert| Viewpoint
CPSC Chairman Vows that Every CPSC Voluntary Corrective Action Will Be Called a “Recall”
May 17, 2016| Blog| Viewpoint
Major U.S. Companies Launch Renewable Energy Buyers Alliance
May 16, 2016| Blog| Viewpoint
OIG Issues Favorable GPO Advisory Opinion
May 16, 2016| Blog| Viewpoint
Supreme Court Decision in Spokeo Breathes Life Into Standing Defenses
May 16, 2016| Blog| Viewpoint
Millions more white-collar workers could get overtime
May 16, 2016| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|